Novo set for India debut of Ozempic this month

Danish drugmaker Novo Nordisk will launch its blockbuster diabetes drug Ozempic in India this month, three sources familiar with the matter said, as it seeks to strengthen its foothold in the most populous nation.

- Reuters

India has the second-highest number of people with type 2 diabetes after China and rising obesity rates, making it a critical battleground for drug-makers vying the fast-growing weight-loss treatment market, which analysts expect to reach $150 billion annually by the end of the decade.